| 2026-08-21 17:00 |
8-K |
["2.01", "7.01"] |
other |
0.05
|
Asset sale completion (SimpliDerm business to Cellution Biologics); not indicative of M&A targeting ELUT. |
SEC · detail |
| 2026-08-13 16:15 |
8-K |
["2.02", "9.01"] |
other |
0.05
|
Routine earnings announcement with no M&A signals or strategic transaction indicators. |
SEC · detail |
| 2026-08-07 16:15 |
8-K |
["3.01", "9.01"] |
other |
0.05
|
Nasdaq minimum bid price deficiency notice; no M&A indicators present. |
SEC · detail |
| 2026-07-20 16:06 |
8-K |
["1.01"] |
material agreement |
0.15
|
Asset sale of SimpliDerm business unit to Cellution Biologics; non-M&A divestiture by ELUT. |
SEC · detail |
| 2026-06-16 17:00 |
8-K |
["5.02", "5.07", "9.01"] |
other |
0.05
|
Routine annual meeting with stock plan amendment approval; no M&A signals detected. |
SEC · detail |
| 2026-05-14 16:06 |
8-K |
["2.02", "9.01"] |
other |
0.05
|
Routine Q1 earnings announcement; no M&A, strategic review, or transaction signals present. |
SEC · detail |